Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported annual fiscal-period values; no daily interpolation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
-3.74x
EV/EBIT RATIO AVG 3Y
-5.94x
EV/EBIT RATIO AVG 5Y
-19.44x
EV/EBIT RATIO AVG 10Y
-25.60x
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Teladoc Health, Inc.
Market Cap
$1.30B
EV/EBIT Ratio
N/A
TTM Avg
-3.74x
3Y Avg
-5.94x
5Y Avg
-19.44x
Market Cap
$427.00M
EV/EBIT Ratio
N/A
TTM Avg
-15.91x
3Y Avg
-20.06x
5Y Avg
-20.06x
Market Cap
$2.43B
EV/EBIT Ratio
13.07x
TTM Avg
19.48x
3Y Avg
19.48x
5Y Avg
20.94x
Market Cap
$2.90B
EV/EBIT Ratio
44.37x
TTM Avg
49.50x
3Y Avg
65.92x
5Y Avg
65.92x
Market Cap
$7.05B
EV/EBIT Ratio
259.98x
TTM Avg
122.21x
3Y Avg
156.68x
5Y Avg
156.68x
Market Cap
$7.23B
EV/EBIT Ratio
8.34x
TTM Avg
425.09x
3Y Avg
149.13x
5Y Avg
149.13x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.30B | N/A | -3.74x | -5.94x | -19.44x |
| NRC Health (NRC)vs › | $458.40M | 34.96x | 19.14x | 18.08x | 19.54x |
| Shoulder Innovations, Inc. (SI)vs › | $427.00M | N/A | -15.91x | -20.06x | -20.06x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.43B | 13.07x | 19.48x | 19.48x | 20.94x |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | -0.28x | -1.89x | -7.82x |
| TransMedics Group, Inc. (TMDX)vs › | $2.90B | 44.37x | 49.50x | 65.92x | 65.92x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.05B | 259.98x | 122.21x | 156.68x | 156.68x |
| Oscar Health, Inc. (OSCR)vs › | $7.23B | 8.34x | 425.09x | 149.13x | 149.13x |
| Tempus AI, Inc. (TEM)vs › | $9.12B | N/A | -25.82x | -27.80x | -28.85x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.49B | 42.13x | 38.96x | 33.13x | 33.08x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2025-12-31 | -5.68x |
| 2024-12-31 | -1.80x |
| 2023-12-31 | -15.95x |
| 2022-12-31 | -0.33x |
| 2021-12-31 | -55.70x |
| 2020-12-31 | -37.21x |
| 2019-12-31 | -74.23x |
| 2018-12-31 | -45.93x |
| 2017-12-31 | -27.80x |
| 2016-12-31 | -11.06x |
| 2015-12-31 | -5.90x |
| 2014-12-31 | -33.28x |
| 2013-12-31 | -89.36x |
